vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and SILICON LABORATORIES INC. (SLAB). Click either name above to swap in a different company.

SILICON LABORATORIES INC. is the larger business by last-quarter revenue ($208.2M vs $134.9M, roughly 1.5× CareTrust REIT, Inc.). On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 25.2%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 39.9%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Silicon Laboratories, Inc., commonly referred to as Silicon Labs, is a fabless global technology company that designs and manufactures semiconductors, other silicon devices and software, which it sells to electronics design engineers and manufacturers in Internet of Things (IoT) infrastructure worldwide.

CTRE vs SLAB — Head-to-Head

Bigger by revenue
SLAB
SLAB
1.5× larger
SLAB
$208.2M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+29.9% gap
CTRE
55.1%
25.2%
SLAB
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
39.9%
SLAB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTRE
CTRE
SLAB
SLAB
Revenue
$134.9M
$208.2M
Net Profit
$111.3M
Gross Margin
63.4%
Operating Margin
-1.6%
Net Margin
82.5%
Revenue YoY
55.1%
25.2%
Net Profit YoY
113.5%
EPS (diluted)
$0.52
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
SLAB
SLAB
Q1 26
$208.2M
Q4 25
$134.9M
$206.0M
Q3 25
$132.4M
$192.8M
Q2 25
$112.5M
$177.7M
Q1 25
$96.6M
Q4 24
$86.9M
$166.2M
Q3 24
$77.4M
$166.4M
Q2 24
$68.9M
$145.4M
Net Profit
CTRE
CTRE
SLAB
SLAB
Q1 26
Q4 25
$111.3M
$-9.9M
Q3 25
$74.9M
$-21.8M
Q2 25
$68.5M
Q1 25
$65.8M
Q4 24
$52.1M
Q3 24
$33.4M
$-28.5M
Q2 24
$10.8M
$-82.2M
Gross Margin
CTRE
CTRE
SLAB
SLAB
Q1 26
63.4%
Q4 25
57.8%
Q3 25
56.1%
Q2 25
55.0%
Q1 25
Q4 24
54.3%
Q3 24
54.3%
Q2 24
52.7%
Operating Margin
CTRE
CTRE
SLAB
SLAB
Q1 26
-1.6%
Q4 25
-6.0%
Q3 25
58.1%
-11.9%
Q2 25
61.3%
-18.1%
Q1 25
Q4 24
-17.2%
Q3 24
43.0%
-17.9%
Q2 24
15.1%
-33.0%
Net Margin
CTRE
CTRE
SLAB
SLAB
Q1 26
Q4 25
82.5%
-4.8%
Q3 25
56.6%
-11.3%
Q2 25
60.9%
Q1 25
68.1%
Q4 24
60.0%
Q3 24
43.2%
-17.1%
Q2 24
15.6%
-56.5%
EPS (diluted)
CTRE
CTRE
SLAB
SLAB
Q1 26
$-0.07
Q4 25
$0.52
$-0.30
Q3 25
$0.35
$-0.67
Q2 25
$0.35
$-0.94
Q1 25
$0.35
Q4 24
$0.30
$-0.72
Q3 24
$0.21
$-0.88
Q2 24
$0.07
$-2.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
SLAB
SLAB
Cash + ST InvestmentsLiquidity on hand
$198.0M
$443.6M
Total DebtLower is stronger
$894.2M
Stockholders' EquityBook value
$4.0B
$1.1B
Total Assets
$5.1B
$1.3B
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
SLAB
SLAB
Q1 26
$443.6M
Q4 25
$198.0M
$439.0M
Q3 25
$712.5M
$415.5M
Q2 25
$306.1M
$424.8M
Q1 25
$26.5M
Q4 24
$213.8M
$382.2M
Q3 24
$377.1M
$369.7M
Q2 24
$495.1M
$339.2M
Total Debt
CTRE
CTRE
SLAB
SLAB
Q1 26
Q4 25
$894.2M
Q3 25
$893.8M
Q2 25
$1.2B
Q1 25
$822.1M
Q4 24
$396.9M
Q3 24
$396.7M
Q2 24
$671.1M
Stockholders' Equity
CTRE
CTRE
SLAB
SLAB
Q1 26
$1.1B
Q4 25
$4.0B
$1.1B
Q3 25
$4.0B
$1.1B
Q2 25
$3.3B
$1.1B
Q1 25
$2.9B
Q4 24
$2.9B
$1.1B
Q3 24
$2.4B
$1.1B
Q2 24
$1.9B
$1.1B
Total Assets
CTRE
CTRE
SLAB
SLAB
Q1 26
$1.3B
Q4 25
$5.1B
$1.3B
Q3 25
$5.1B
$1.2B
Q2 25
$4.7B
$1.2B
Q1 25
$3.9B
Q4 24
$3.4B
$1.2B
Q3 24
$2.9B
$1.2B
Q2 24
$2.7B
$1.2B
Debt / Equity
CTRE
CTRE
SLAB
SLAB
Q1 26
Q4 25
0.22×
Q3 25
0.22×
Q2 25
0.35×
Q1 25
0.28×
Q4 24
0.14×
Q3 24
0.16×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
SLAB
SLAB
Operating Cash FlowLast quarter
$394.0M
$8.3M
Free Cash FlowOCF − Capex
$-1.6M
FCF MarginFCF / Revenue
-0.8%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters
$65.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
SLAB
SLAB
Q1 26
$8.3M
Q4 25
$394.0M
$34.3M
Q3 25
$100.9M
$4.9M
Q2 25
$100.8M
$48.1M
Q1 25
$71.4M
Q4 24
$244.3M
$10.1M
Q3 24
$67.2M
$31.6M
Q2 24
$53.0M
$16.1M
Free Cash Flow
CTRE
CTRE
SLAB
SLAB
Q1 26
$-1.6M
Q4 25
$27.9M
Q3 25
$-3.8M
Q2 25
$43.3M
Q1 25
Q4 24
$6.2M
Q3 24
$29.4M
Q2 24
$12.6M
FCF Margin
CTRE
CTRE
SLAB
SLAB
Q1 26
-0.8%
Q4 25
13.6%
Q3 25
-2.0%
Q2 25
24.4%
Q1 25
Q4 24
3.7%
Q3 24
17.7%
Q2 24
8.7%
Capex Intensity
CTRE
CTRE
SLAB
SLAB
Q1 26
4.8%
Q4 25
3.1%
Q3 25
4.5%
Q2 25
2.7%
Q1 25
Q4 24
2.4%
Q3 24
1.3%
Q2 24
2.4%
Cash Conversion
CTRE
CTRE
SLAB
SLAB
Q1 26
Q4 25
3.54×
Q3 25
1.35×
Q2 25
1.47×
Q1 25
1.08×
Q4 24
4.68×
Q3 24
2.01×
Q2 24
4.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRE
CTRE

Segment breakdown not available.

SLAB
SLAB

Sales Channel Through Intermediary$157.5M76%
Sales Channel Directly To Consumer$50.7M24%

Related Comparisons